MedPath

Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

Not Applicable
Recruiting
Conditions
Hypertension
Registration Number
NCT06997445
Lead Sponsor
Foundation University Islamabad
Brief Summary

The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.

Detailed Description

The study will consist of referred stage 1 hypertensive patients by medical specialist/cardiologist.

Participants will be screened through PAR-Q and IPAQ Questionnaire. Cardiac monitor will be used for assessing the cardiopulmonary parameters. SF-36 Questionnaire will be used for assessing the quality of life. Informed written consent will be taken after which participants will be recruited into two groups.

Control group will be provided aerobic exercise while interventional group will be provided Jacobson's progressive muscle relaxation technique with aerobic exercise.

Outcome measures assessment will be done at pre-session, at 2 weeks and after 4 weeks post-intervention

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adults: aged (18-45 years)
  • Gender: both male and female
  • Patients diagnosed with stage 1 hypertension (130-139 / 80-89 mmHg according to AHA/ACC 2017 guidelines
  • Mild to moderate physical activity level on IPAQ Questionnaire
  • Individuals who are able to understand and follow the instructions for exercise
Exclusion Criteria
  • Unstable angina, MI, heart failure, advanced CAD patients
  • Severe neurological, musculoskeletal, or gynaecological conditions which limit participation in study
  • Recent history of fracture
  • Morbidly obese (BMI > 40.0 kg / m2)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Systolic and diastolic blood pressure04 Weeks

Evaluation will be done using cardiac monitor for blood pressure.

Heart rate04 Weeks

It will be measured through pulse oximeter.

Respiratory rate04 Weeks

It will be measured by counting the number of breaths a person takes per minute

Rate pressure product04 Weeks

It will be calculated by multiplying heart rate with systolic blood pressure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Foundation University College of Physical Therapy, Islamabad, 44000

🇵🇰

Islamabad, Pakistan

© Copyright 2025. All Rights Reserved by MedPath